» Articles » PMID: 36932827

Advanced Hybrid Closed Loop System Use in Elderly with Type 1 Diabetes: Effectiveness and Safety in a Prospective, Observational, 1-year Follow-up Real-world Study

Overview
Specialty Endocrinology
Date 2023 Mar 18
PMID 36932827
Authors
Affiliations
Soon will be listed here.
Citing Articles

MiniMed 780G system performance in older users with type 1 diabetes: Real-world evidence and the case for stricter glycaemic targets.

Smaniotto V, Heller S, ONeal D, Jendle J, Cukierman-Yaffe T, Arrieta A Diabetes Obes Metab. 2025; 27(4):2242-2250.

PMID: 39905659 PMC: 11885105. DOI: 10.1111/dom.16227.


Twelve-Month Real-World Use of an Advanced Hybrid Closed-Loop System Versus Previous Therapy in a Dutch Center For Specialized Type 1 Diabetes Care.

Dekker P, Van den Heuvel T, Arrieta A, Castaneda J, Mul D, Veeze H J Diabetes Sci Technol. 2024; :19322968241290259.

PMID: 39465557 PMC: 11571609. DOI: 10.1177/19322968241290259.


12-Month Time in Tight Range Improvement with Advanced Hybrid-Closed Loop System in Adults with Type 1 Diabetes.

Nigi L, Simon Batzibal M, Cataldo D, Dotta F Diabetes Ther. 2024; 15(12):2557-2568.

PMID: 39347899 PMC: 11561210. DOI: 10.1007/s13300-024-01656-w.


Ageing well with diabetes: the role of technology.

Maltese G, McAuley S, Trawley S, Sinclair A Diabetologia. 2024; 67(10):2085-2102.

PMID: 39138689 PMC: 11446974. DOI: 10.1007/s00125-024-06240-2.


How can we reach the target of glucose control in type 1 diabetes?.

Bloomgarden Z J Diabetes. 2023; 15(6):462-464.

PMID: 37211953 PMC: 10270742. DOI: 10.1111/1753-0407.13413.